USP Helps Cambodia, Southeast Asia Build Arsenal To Combat Counterfeit Drugs
This article was originally published in PharmAsia News
Executive SummaryBEIJING - In the latest moves aimed at fighting counterfeit medicines being sold to patients with malaria or other potentially lethal diseases, the United States Pharmacopeial Convention is training Cambodian scientists to test drugs for quality and authenticity, expanding a new system to track adverse events, and producing television spots to educate the public about the dangers of fake drugs. The USP is conducting a similar offensive against counterfeit drugs throughout Southeast Asia under a cooperative agreement with the United States Agency for International Development
You may also be interested in...
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).